We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$147M
AUM Growth
-$656K
Cap. Flow
-$4.23M
Cap. Flow %
-2.87%
Top 10 Hldgs %
22.95%
Holding
189
New
25
Increased
30
Reduced
84
Closed
26

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$1.28M
2
FL
Foot Locker
FL
+$1.12M
3
LLY icon
Eli Lilly
LLY
+$1.08M
4
LEN icon
Lennar Class A
LEN
+$1.02M
5
CRL icon
Charles River Laboratories
CRL
+$946K

Top Sells

Rank Stock Value
1
AZTA icon
Azenta
AZTA
+$1.9M
2
MKC icon
McCormick & Company Non-Voting
MKC
+$1.41M
3
VMC icon
Vulcan Materials
VMC
+$1.17M
4
VLO icon
Valero Energy
VLO
+$1M
5
AYI icon
Acuity Brands
AYI
+$966K

Sector Composition

Rank Sector Weight
1 Healthcare 20.14%
2 Industrials 16.02%
3 Technology 14.42%
4 Consumer Staples 13.67%
5 Financials 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHD icon
1
Church & Dwight Co
CHD
$23.4B
$5.68M 3.85%
77,750
-2,250
-3% -$167K
JNJ icon
2
Johnson & Johnson
JNJ
$618B
$4.57M 3.1%
32,827
-2,024
-6% -$280K
CSCO icon
3
Cisco
CSCO
$457B
$4.56M 3.1%
83,400
-700
-0.8% -$38.7K
WASH icon
4
Washington Trust Bancorp
WASH
$743M
$3.77M 2.56%
72,172
– –
DIS icon
5
Walt Disney
DIS
$167B
$3.07M 2.08%
21,980
-2,275
-9% -$302K
INTC icon
6
Intel
INTC
$455B
$2.92M 1.98%
60,937
+7,874
+15% +$390K
KMB icon
7
Kimberly-Clark
KMB
$36.3B
$2.77M 1.88%
20,788
-100
-0.5% -$12.9K
AAPL icon
8
Apple
AAPL
$4.54T
$2.23M 1.52%
45,176
-3,000
-6% -$146K
ABT icon
9
Abbott
ABT
$183B
$2.13M 1.45%
25,378
-400
-2% -$31.5K
PFE icon
10
Pfizer
PFE
$143B
$2.12M 1.44%
51,524
-263
-0.5% -$10.4K
EL icon
11
Estee Lauder
EL
$30.4B
$2.12M 1.44%
11,550
-425
-4% -$72.6K
KO icon
12
Coca-Cola
KO
$377B
$2.1M 1.43%
41,325
-125
-0.3% -$6.13K
ZTS icon
13
Zoetis
ZTS
$32.4B
$2.05M 1.39%
18,073
– –
MSFT icon
14
Microsoft
MSFT
$3.45T
$2M 1.36%
14,934
– –
MRK icon
15
Merck
MRK
$322B
$1.99M 1.35%
24,885
-576
-2% -$44.1K
XOM icon
16
ExxonMobil
XOM
$644B
$1.95M 1.32%
25,461
-150
-0.6% -$11.6K
CVS icon
17
CVS Health
CVS
$133B
$1.9M 1.29%
34,950
+1,300
+4% +$70K
UAL icon
18
United Airlines
UAL
$39.4B
$1.9M 1.29%
21,748
+1,100
+5% +$93.1K
CSX icon
19
CSX Corp
CSX
$93.4B
$1.88M 1.27%
72,825
– –
CCL icon
20
Carnival Corporation Ltd
CCL
$38.1B
$1.83M 1.24%
39,253
+4,875
+14% +$255K
AMGN icon
21
Amgen
AMGN
$208B
$1.8M 1.22%
9,762
+150
+2% +$26.9K
UPS icon
22
United Parcel Service
UPS
$88.6B
$1.63M 1.11%
15,776
+2,251
+17% +$234K
BMY icon
23
Bristol-Myers Squibb
BMY
$133B
$1.5M 1.02%
33,037
-700
-2% -$32.6K
BRK.B icon
24
Berkshire Hathaway Class B
BRK.B
$1.1T
$1.49M 1.01%
6,986
-150
-2% -$31K
PG icon
25
Procter & Gamble
PG
$336B
$1.49M 1.01%
13,576
-275
-2% -$29.3K
1
2 3 4 5

Similar funds

GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return
PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
TC
Towle & Co Denver, Colorado $257M AUM 73.13% 1-Year Est. Return

New England Research & Management's Q2 2019 Portfolio in Review

As of Q2 2019, New England Research & Management held 189 positions worth $147M, down 0.44% from $148M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q2 2019 filing shows 25 new, 30 increased, 84 reduced and 26 closed positions. Its largest new stake was RTX Corp: 15,334 shares worth $1.26M. The largest sale was Azenta, an estimated $1.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

  • New England Research & Management's largest Q2 2019 buy was RTX Corp: 15,334 shares worth $1.26M.
  • New England Research & Management added most to M.D.C. Holdings, Inc. in Q2 2019, an estimated $669K increase.
  • New England Research & Management's biggest Q2 2019 reduction was Azenta, cutting an estimated $1.9M.
  • New England Research & Management fully exited McCormick & Company Non-Voting in Q2 2019, selling an estimated $1.41M.
  • New England Research & Management's ten largest holdings make up 23% of its $147M portfolio in Q2 2019.
  • New England Research & Management opened 25 new positions and closed 26 in Q2 2019.
  • New England Research & Management's portfolio value fell 0.44% quarter-over-quarter to $147M.

Based on New England Research & Management's 13F filing for Q2 2019, filed 9 Jul 2019.